Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Lung Biotechnology

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$40M
Portfolio companies 2
Rounds per year 0.17
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Exits 1
Key employees Soon

Areas of investment

  • Health Care
  • Medical
  • Medical Device
  • Biotechnology
Summary

Lung Biotechnology is the famous Corporate Investor, which was founded in 1997. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Silver Spring.

The standard case for the fund is to invest in rounds with 8 partakers. Despite the Lung Biotechnology, startups are often financed by Kleiner Perkins, Flagship Pioneering, Abrams Capital. The meaningful sponsors for the fund in investment in the same round are Kleiner Perkins, Inbio Ventures, Flagship Pioneering. In the next rounds fund is usually obtained by Pharmstandard, Kleiner Perkins, Inbio Ventures.

The top amount of exits for fund were in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2016.

Besides, a startup needs to be aged 16-20 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline TransMedics For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Medical, Health Care.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
724 Solutions Canada, Ontario, Toronto
Aream & Co England, London, United Kingdom
BOCOM International China, Hong Kong, Hong Kong Island
Citrosuco -
Fengshi Equity Investment Management China, Shanghai
Future Corp Japan, Tokyo
hackNY New York, New York, United States
Norsk Hydro ASA Norway, Oslo
PointGuard Ventures California, Menlo Park, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Lung Biotechnology?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 40M
Rounds per year 0.17
Peak activity year 2016
Lead investments 1
Follow on index 0.50
Exits 1
Group Appearance index 0.50
Crunchbase icon

Content report

The following text will be sent to our editors: